lorglumide

Suppliers

Names

[ CAS No. ]:
97964-56-2

[ Name ]:
lorglumide

[Synonym ]:
(+/-)-4-[3,4-dichlorobenzoylamino]-5-(dipentylamino)-5-oxopentanoate
cr1409
4-dichlorobenzoyl)amino)-5-(dipentylamino)-5-oxo-4-(((+-)-pentanoicaci
(R,S-4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoic acid)
D,L-4-(3,4-dichloro-benzoyl-amino)-5-(di-n-pentyl-amino)-5-oxo-pentanoic acid
MFCD00083183
d,l-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pentanoicacid

Chemical & Physical Properties

[ Density]:
1.195g/cm3

[ Boiling Point ]:
621.4ºC at 760mmHg

[ Molecular Formula ]:
C22H32Cl2N2O4

[ Molecular Weight ]:
459.40600

[ Flash Point ]:
329.6ºC

[ Exact Mass ]:
458.17400

[ PSA ]:
86.71000

[ LogP ]:
5.55650

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
SA3680700
CHEMICAL NAME :
Pentanoic acid, 4-((3,4-dichlorobenzoyl)amino)-5-(dipentylamino)-5-ox o-, (+-)-
CAS REGISTRY NUMBER :
97964-56-2
LAST UPDATED :
199106
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C22-H32-Cl2-N2-O4
MOLECULAR WEIGHT :
459.46

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 37,1265,1987
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
199 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 37,1265,1987

Safety Information

[ WGK Germany ]:
2

[ RTECS ]:
SA3680700

Related Compounds

  • lorglumide
  • Lorglumide sodium salt
  • benzyl N-[(2S,3S)-2-hydroxypentan-3-yl]carbamate
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide